Group 1: Company Overview - Beijing Kain Technology Co., Ltd. held its Q3 2024 earnings briefing on December 6, 2024 [2][3] - The meeting aimed to enhance communication with investors and provide a comprehensive understanding of the company's performance [6] Group 2: Shareholder Information - As of November 30, 2024, the number of shareholders reached 7,874 [6] - The company emphasizes the importance of shareholder engagement and feedback [6] Group 3: Financial Performance - The company reported a cumulative revenue of 1.011 billion yuan for the first three quarters of 2024 [6] - Kain Technology is committed to value management and believes that strong operational performance is the foundation for enhancing market value [6][8] Group 4: Investor Relations - The company actively engages in cash dividends and share buybacks to reward investors [8] - Kain Technology plans to strengthen communication with investors to continuously improve its market value [8] Group 5: Product Development - The application for additional indications for the product "Pai Yisheng" has been approved by the National Medical Products Administration and is expected to be launched soon [8]
凯因科技(688687) - 凯因科技投资者关系活动记录表